Repositorio de producción científica de la Universidad de Sevilla

Metformin treatment decreases microglial activation in the in vivo lps model of parkinson's disease.

 

Advanced Search
 
Opened Access Metformin treatment decreases microglial activation in the in vivo lps model of parkinson's disease.
Cites
Show item statistics
Icon
Export to
Author: Tayara, Khadija
Director: Espinosa Oliva, Ana María
Martínez de Pablos, Rocío
Department: Universidad de Sevilla. Departamento de Bioquímica y Biología Molecular
Date: 2018-11-23
Document type: Doctoral Thesis
Abstract: Metformin is a widely used oral antidiabetic drug with known anti-inflammatory properties due to its action on AMP kinase. This drug has shown a protective effect on various brain tissues, including cortical neurons. However, the effect of metformin...
[See more]
La metformina es un fármaco antidiabético oral ampliamente utilizado con propiedades antiinflamatorias conocidas debido a su acción sobre la AMP cinasa. Esta droga ha mostrado un efecto protector en varios tejidos del cerebro, incluidas las neuronas...
[See more]
Cite: Tayara, K. (2018). Metformin treatment decreases microglial activation in the in vivo lps model of parkinson's disease.. (Tesis Doctoral Inédita). Universidad de Sevilla, Sevilla.
Size: 7.611Mb
Format: PDF

URI: https://hdl.handle.net/11441/80743

This work is under a Creative Commons License: 
Attribution-NonCommercial-NoDerivatives 4.0 Internacional

This item appears in the following Collection(s)